Functional Significance of Aurora Kinases–p53 Protein Family Interactions in Cancer
Open Access
- 25 November 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 6, 247
Abstract
Aurora kinases play critical roles in regulating spindle assembly, chromosome segregation and cytokinesis to ensure faithful segregation of chromosomes during mitotic cell division cycle. Molecular and cell biological studies have revealed that Aurora kinases, at physiological levels, orchestrate complex sequential cellular processes at distinct subcellular locations through functional interactions with its various substrates. Aberrant expression of Aurora kinases, on the other hand, cause defects in mitotic spindle assembly, checkpoint response activation and chromosome segregation leading to chromosomal instability. Elevated expression of Aurora kinases correlating with chromosomal instability is frequently detected in human cancers. Recent genomic profiling of about 3000 human cancer tissue specimens to identify various oncogenic signatures in the Cancer Genome Atlas (TCGA) project has reported that recurrent amplification and overexpression of Aurora kinase-A characterize distinct subsets of human tumors across multiple cancer types. Besides the well characterized canonical pathway interactions of Aurora kinases in regulating assembly of the mitotic apparatus and chromosome segregation, growing evidence also supports the notion that deregulated expression of Aurora kinases in non-canonical pathways drive transformation and genomic instability by antagonizing tumor suppressor and exacerbating oncogenic signaling through direct interactions with critical proteins. Aberrant expression of the Aurora kinases-p53 protein family signaling axes appears to be critical in the abrogation of p53 protein family mediated tumor suppressor pathways frequently deregulated during oncogenic transformation process. Recent findings reveal the existence of feedback regulatory loops in mRNA expression and protein stability of these protein families and their consequences on downstream effectors involved in diverse physiological functions, such as, mitotic progression, checkpoint response pathways as well as self-renewal and pluripotency in embryonic stem cells. While these investigations have focused on the functional consequences of Aurora kinase protein family interactions with wild-type p53 family proteins, those involving Aurora kinases and mutant p53 remain to be elucidated. This article presents a comprehensive review of studies on Aurora kinases-p53 protein family interactions along with a prospective view on the possible functional consequences of Aurora kinase-mutant p53 signaling pathways in tumor cells. Additionally, we also discuss therapeutic implications of these findings in Aurora kinases overexpressing subsets of human tumors.Keywords
Funding Information
- National Cancer Institute (R01CA089716, NCI/EDRN UO1CA111302)
This publication has 95 references indexed in Scilit:
- A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215Journal of Biological Chemistry, 2004
- Regulation of Xenopus Aurora A Activation by TPX2Journal of Biological Chemistry, 2004
- Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53Nature Genetics, 2003
- Roles of aurora‐A kinase in mitotic entry and G2 checkpoint in mammalian cellsGenes to Cells, 2002
- Suppression of the STK15 oncogenic activity requires a transactivation‐independent p53 functionThe EMBO Journal, 2002
- Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformationNature Genetics, 1998
- A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersThe EMBO Journal, 1998
- Abnormal Centrosome Amplification in the Absence of p53Science, 1996
- SPONTANEOUS ABNORMALITIES IN NORMAL FIBROBLASTS FROM PATIENTS WITH LI-FRAUMENI CANCER SYNDROME - ANEUPLOIDY AND IMMORTALIZATION1990